Giltech Announces Appointment of Advisory Group to Develop Strategic Partnerships for its Healthcare Technology
Date: 01 Jun 2012
Ayr, Scotland, UK – June 2012 – Giltech (www.giltech.biz) is pleased to announce that it has appointed The Sage Group as advisors to develop strategic corporate partnerships in healthcare globally.
Giltech was founded more than 25 years ago and is based in Ayr, Scotland. The Company has a long history of innovative product development in the biomaterials space. Giltech is the company behind pioneering products such as Sorbsan® and its technologies have been used to produce innovative products including Arglaes®. In particular, Giltech owns IP and knowhow relating to alginate foams and biodegradable phosphate polymers. Application areas include wound management, regenerative medicine and microbial control.
The Company has a proven track record of collaborating successfully with partner companies to support innovative new product development to the stage where a particular product can be launched or subjected to commercial evaluation. Giltech operates in-house development, engineering, computing and analytical facilities and manufactures Corglaes® , its proprietary biodegradable phosphate polymer, in-house, which helps protect its intellectual property in this area and provide on-going support to its commercial activities.
Giltech already has a number of existing commercial relationships with medical device companies in Europe and North America and is seeking to extend its commercial outreach by development of new strategic partnerships for R&D, novel product development and manufacturing.
“We are very pleased to announce this alliance, which will have wide-ranging advantages for our global client base,” said Gillian Watson, CEO of Giltech. “Giltech's strong healthcare technology focus has the potential to bring a new and highly innovative product development dimension to the services we can provide our clients. We are delighted to be working with The Sage Group. They will be able to enhance significantly our ability to serve our clients’ business and product development needs on a global basis and to develop new partnerships for Giltech.”
For further information, please contact either Giltech or The Sage Group direct.
Giltech Limited (“Giltech” or the “Company”) is based in Ayrshire, Scotland. The Company has more than twenty five years of expertise in novel biomedical materials technology. Giltech technologies have been used to produce pioneering products including Sorbsan® and Arglaes®.
The Company’s current activities focus on two core materials platforms, which offer its partners distinct technology advantages:
Algisan™ alginate foams for high performance wound care treatments
Corglaes® water-soluble phosphate polymers:
CorGlaes® Pure for bioresorbable implants and tissue scaffolds
CorGlaes® Active for delivery of bioactive metal ions, such as silver in anti-microbial applications
CorGlaes® is already an essential ingredient in some of the world’s leading medical and healthcare products.
Giltech has a powerful blend of versatile technology platforms, deep technical expertise and highly specialised manufacturing processes which enables it to deliver a distinct competitive advantage by offering custom formulations of its technologies for each of its partners.
12 North Harbour Estate
Ayr KA8 8BN
Tel: +44 1292 264406
About The Sage Group, Inc.
The Sage Group Inc. is a leader in the provision of strategic and transactional advice to health care companies in the pharmaceutical, diagnostics, medical device, biotechnology and life science fields. Sage currently maintains offices in USA, Europe, Israel, Australia and Japan. Since its founding in 1994, The Sage Group has served more than 200 clients in the US, Europe and Asia, and completed numerous transactions including divestitures, alliances, acquisitions and financings with values ranging from $5 million to $500 million.
The Sage Group is an organization of experienced and successful executives who are committed to the service of the very vital and dynamic health care industry and its investors.
The Sage Group's Principals, each an Executive Director, have been Founders, Chairmen, Presidents, CEO's and COO's of a number of emerging health care companies. These Principals have also held senior level management positions in large multi-national organizations. In addition to their management backgrounds, The Sage Group's Principals also have extensive experience in providing professional management consulting services to healthcare industry clients. All these experiences are being applied by The Sage Group to assist industry participants in these challenging times.